Cybrexa Therapeutics to Present Virtually at H.C. Wainwright 23rd Annual Global Investment Conference
10 sept. 2021 09h57 HE
|
Cybrexa Therapeutics
NEW HAVEN, Conn., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ Peptide Drug...